CHREBP Antibody (LS-B171)

貨號 Cat. No.
LS-B171
規格 Size
50 µl
品牌 Brand
LSBio

Description

















































































Antibody Catalog ID: LS-B171
Antibody Validation: This antibody replaces catalog number LS-C2546. It has been validated for use in the following assays: IHC.
Antibody Target: Williams-Beuren Syndrome Chromosome Region 14 (WBSCR14) (CHREBP) (MLXIPL)
Synonyms: MLXIPL, CHREBP, MONDOB, WBSCR14
Host: MLXIPL antibody was produced in Rabbit
Antigen Species: MLXIPL antibody was raised against Human
Clonality: Polyclonal
Antigen Type: Synthetic peptide - KLH conjugated
Immunogen: MLXIPL antibody was raised against synthetic peptide
Antibody Specificity: A C-terminal synthetic peptide made to the human ChREBP protein sequence (between residues 800-852).
Antigen Modification: aa800-852
Predicted Species Reactivity: Mouse, Rat
Purification: Immunoaffinity Chromatography
Presentation: Contains 0.1% sodium azide
Recommended Storage: +4°C or -20°C, Avoid repeated freezing and thawing.
Antibody Usage Summary: Immunohistochemistry: LS-B171 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody LS-D1, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B171 was determined to be 2.5 ug/ml.
Antibody Uses: Immunohistochemistry - Paraffin (IHC-P) (2.5 µg/ml), Western blot (WB) (1:1000 - 1:3000), Immunofluorescence (IF) (1:100 - 1:500) (Optimal dilution to be determined by the researcher)
Size: 50 µl
Concentration: 1 mg/ml

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢